Skip to main content

Table 13 Molecular structures, predicted pIC50 and MolDock scores of the newly designed arylimidamide-azole analogs

From: A combined 2-D and 3-D QSAR modeling, molecular docking study, design, and pharmacokinetic profiling of some arylimidamide-azole hybrids as superior L. donovani inhibitors